The healthcare industry is experiencing a data deluge, and it shows no sign of slowing down.
In 2020, estimates reported that healthcare data comprised a staggering 30% of the world’s total data volume; projections for 2025 bump that number up to 36%, a growth rate outpacing every other industry.
This is promising news for precision medicine, the data-driven healthcare initiative that promotes the right treatment for the right patient at the right time.
Precision (or personalized)
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
Tempus Launches Pathology-Driven AI Platform
What You Should Know:
- Tempus, a provider of artificial intelligence and precision medicine, today announced the launch of Edge, an innovative platform that allows pathologists to access developing AI models intended to identify specimens with potentially actionable biomarkers using a single hematoxylin and eosin stain (H&E) slide.
- With access to over 50 petabytes of de-identified multimodal data, Tempus is developing AI models with the aim to identify patients who would
Read More
EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment in Children
What You Should Know:
- EarliTec Dx, a digital health company developing novel diagnostic and therapeutic products for children with Autism Spectrum Disorder (ASD) and early childhood vulnerabilities, today announced a $19.5 million financing led by Bernie Marcus, with participation from the Georgia Research Alliance (GRA).
- This round of financing will be used to support filing with the U.S. Food and Drug Administration (FDA) for 510K clearance, as well as commercialization of the
Read More
Beacon Biosignals Secures $27M to Scale EEG Neurobiomarker Discovery Platform
What You Should Know:
- Beacon Biosignals, a neurotechnology company applying artificial intelligence to EEG (electroencephalography) to unlock precision medicine for any condition affecting the brain, has announced an oversubscribed $27M Series A financing led by General Catalyst and with participation from Casdin Capital. This capital brings Beacon Biosignals' total funding to date to $30M.
- Founded in 2019 by MD/PhDs and engineers from Harvard and MIT, Beacon's launch was propelled by
Read More
Sonde Health Launches Vocal Biomarker Tech to Monitor Mental Health and Well-Being
What You Should Know:
- Sonde Health has unveiled Sonde Mental Fitness, a voice-enabled mental health detection and monitoring technology that uses a brief voice sample to evaluate mental well-being. Available as an application programming interface (API) for health systems, employers, and wellness service providers, Sonde Mental Fitness is an easy and affordable way for individuals to engage with and better understand their mental well-being and can serve as a much-needed early warning
Read More
To Advance Health Equity, Put Real-World Cancer Data to Work
Despite decades of scientific progress against cancer, access to treatment remains highly unequal. Some of the reasons — like institutional racism and poverty — are a reflection of our broader society. Other inequities may go unrecognized but are no less damaging. People with underlying health conditions, for example, may be excluded from clinical trials, preventing them from accessing leading-edge treatments and limiting the evidence available to guide their care.
With multiple drivers of
Read More
DaVita & RenalytixAI Partner for Early Risk Identification to Help Slow Kidney Disease Progression
What You Should Know:
- RenalytixAI and DaVita announce a program partnership that
aims to slow kidney disease progression and improve outcomes for the nation’s
estimated 37 million adults with chronic kidney disease (CKD).
- This is the first clinical-grade program that delivers
advanced early-stage prognosis and risk stratification, combined with
actionable care management to the primary care level where the majority of
kidney disease patients are being seen.
- The program will use
Read More
30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021.
Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare
Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models
Read More
Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection
What You Should Know:
- Mayo Clinic announced a collaboration with Vocalis
Health to to research and develop new voice-based tools for screening, detecting
and monitoring patient health, beginning with a study to identify vocal
biomarkers to detect pulmonary hypertension (PH).
- The clinical validation study will utilize Vocalis
Health’s proprietary software, which can operate on any connected voice
platform (mobile, computer, tablet, etc.) to analyze patients’ health based on
voice
Read More
Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors
What You Should Know:
- Clinical trials technology company Medidata has
acquired the digital biomarker business of MC10.
- MC10’s offerings will bring novel clinical analytics
and biosensor capabilities to Medidata’s existing technology solutions,
enhancing Medidata’s capabilities to integrate data from wearable sensors –
including clinical grade metrics – in clinical trials.
- With this acquisition, Medidata’s integrated offering
will help provide life sciences companies and device
Read More
